Donate

Tag: MDMA

The FDA’s Rejection on MDMA-Assisted Therapy: What is Next for the Psychedelic Movement?

The FDA's call for another phase 3 study of MDMA-Assisted Therapy delays approval, revealing biomedical...

Will MDMA win FDA Approval?

Recent advisory groups ICER and AdComm have recommended against FDA approval of MDMA for medical...

The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy

Geoff Bathje, initially supportive of Psymposia’s critiques within the psychedelic field, has grown skeptical of...

Psychedelic Assisted Therapy with MDMA Stumbles Over Pharmacological Dogma

On June 4, an FDA advisory committee overwhelmingly rejected MDMA-assisted therapy for PTSD, citing inadequate...

Therapists, Trainers, and Researchers from Lykos’ Phase 3 MDMA-Assisted Therapy Studies Respond to Concerns in ICER’s Draft Evidence Report

The Institute for Clinical and Economic Review (ICER), is an independent non-profit research organization that...

An Intersectional Experience of MDMA-Assisted Psychotherapy

Despite the growth of the use of MDMA in the treatment of PTSD, Terence Ching...

Placebo Problems: Boundary Works in the Psychedelic Science Renaissance

The relationship between the placebo and psychedelic research is complicated by the psychological aspects of...

The Chacruna Institute Endorses the Breakthrough Therapies Act

The Chacruna Institute endorses the Breakthrough Therapies Act introduced by Senators Cory Booker and Rand...

Letters in Support of the Right to Try Clarification Act and an Inter-agency Taskforce on Psychedelic Medicines and Therapies

These documents show exchanges between members of the Veteran Mental Health Leadership Coalition (VMHLC) and...
Load More